Michael J. Kamdar
Algemeen Directeur bij Molecular Assemblies, Inc.
Profiel
Michael J.
Kamdar was the founder of VentiRx Pharmaceuticals, Inc. (founded in 2006) where he held the position of Director, Chief Business Officer & EVP.
Mr. Kamdar is also the founder of Avalyn Pharma, Inc. He is currently the President, Chief Executive Officer & Director at Molecular Assemblies, Inc. and the Executive Chairman at Medipacs, Inc. Mr. Kamdar's former positions include Senior Director-Business Development at Agouron Pharmaceuticals LLC, President & Director at Ciclofilin Pharmaceuticals, Inc., Director at Tobira Therapeutics, Inc., Principal at Centocor, Inc. and Hybritech, Inc., and SVP-Finance & Corporate Development at Anadys Pharmaceuticals, Inc. He also served as the President at Cellana LLC.
Mr. Kamdar received his undergraduate degree from St. Joseph's University and his MBA from Villanova University.
Actieve functies van Michael J. Kamdar
Bedrijven | Functie | Begin |
---|---|---|
Medipacs, Inc.
Medipacs, Inc. Electronic Equipment/InstrumentsElectronic Technology Medipacs, Inc. develops infusion pump technology for fluid delivery systems. It offers Mini-Infuser CRI pump that is intended to be used for medication delivery, such as in post-surgical pain management, with 10-60 kg (22 lbs-130 lbs) canines that are under the supervised and direct care of veterinary healthcare professionals in a hospital or acute care setting. The company was founded in 2004 by Mark Banister and is headquartered in San Diego, CA. | Voorzitter | 29-09-2016 |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Molecular Assemblies, Inc. develops an enzymatic deoxyribonucleic acid (DNA) synthesis technology designed to power the next generation of DNA-based products. The firm's technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. The company was founded by William Efcavitch and Curt Becker in 2013 and is headquartered in San Diego, CA. | Algemeen Directeur | - |
Eerdere bekende functies van Michael J. Kamdar
Bedrijven | Functie | Einde |
---|---|---|
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Directeur/Bestuurslid | 01-04-2014 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Financieel Directeur/CFO | 01-06-2005 |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01-01-2001 |
Avalyn Pharma, Inc.
Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Oprichter | - |
Ciclofilin Pharmaceuticals, Inc.
Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Ciclofilin Pharmaceuticals, Inc. develops cyclophilin inhibitors for infectious, inflammatory and degenerative diseases. It offers antiviral drug development, liver disease, viral co-infection, cyclophilin inhibition, macrocycle chemistry and protein folding. The company was founded in 2014 by Robert T. Foster and is headquartered in San Diego, PA. | President | - |
Opleiding van Michael J. Kamdar
St. Joseph's University | Undergraduate Degree |
Villanova University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 11 |
---|---|
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
VentiRx Pharmaceuticals, Inc.
VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA. | Health Technology |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Health Technology |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Hybritech, Inc.
Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA. | Commercial Services |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Cellana LLC
Cellana LLC Agricultural Commodities/MillingProcess Industries Cellana LLC develops biofuels and animal feed from algae. The firm offers DHA nutritional oils, food and animal feed, and biofuel feedstocks. The company was founded by C. Barry Raleigh and is headquartered in Kailua-Kona, HI. | Process Industries |
Ciclofilin Pharmaceuticals, Inc.
Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Ciclofilin Pharmaceuticals, Inc. develops cyclophilin inhibitors for infectious, inflammatory and degenerative diseases. It offers antiviral drug development, liver disease, viral co-infection, cyclophilin inhibition, macrocycle chemistry and protein folding. The company was founded in 2014 by Robert T. Foster and is headquartered in San Diego, PA. | Health Technology |
Medipacs, Inc.
Medipacs, Inc. Electronic Equipment/InstrumentsElectronic Technology Medipacs, Inc. develops infusion pump technology for fluid delivery systems. It offers Mini-Infuser CRI pump that is intended to be used for medication delivery, such as in post-surgical pain management, with 10-60 kg (22 lbs-130 lbs) canines that are under the supervised and direct care of veterinary healthcare professionals in a hospital or acute care setting. The company was founded in 2004 by Mark Banister and is headquartered in San Diego, CA. | Electronic Technology |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Molecular Assemblies, Inc. develops an enzymatic deoxyribonucleic acid (DNA) synthesis technology designed to power the next generation of DNA-based products. The firm's technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. The company was founded by William Efcavitch and Curt Becker in 2013 and is headquartered in San Diego, CA. | Health Technology |
Avalyn Pharma, Inc.
Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Health Technology |